US biotech seed funding hit a staggering $5.2 billion in Q1 2026, signaling robust investor confidence. This article delves into the factors propelling this growth and its implications for the industry.

For US biotech startups navigating 2025, robust intellectual property protection is paramount. This article outlines practical strategies to avoid common pitfalls, ensuring your innovations are safeguarded against infringement and competitive threats.